Harnessing AI and omics for next-generation gene therapy manufacturing
Year: 2025
Type: article
Abstract: “To make AI and ML truly effective, it is essential to integrate domain-specific knowledge.”Abi Pinchbeck, Editor, Cell & Gene Therapy Insights, speaks to Richard D Braatz, Chief Scientist and Co-founder of BioCurie, and Irene Rombel, CEO and Co-founder of BioCurie, about their work in AI-driven software and omics technologies to optimize gene therapy production. They discuss the untapped opportunities in integrating omics data, improving efficiencies, and leveraging AI to enhance therapeutic accessibility.
Source: Cell and Gene Therapy Insights
Authors: Richard Braatz, Irene Rombel
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W7115169122
FWCI:
Cites:
Cited by:
Related to: